Skip to main content
menu

April 2022

Meet Our Latest KL2 Career Development Awardees

Meet Our Latest KL2 Career Development Awardees

Congratulations to the latest cohort of KL2 Career Development Awardees funded by the UR CTSI! This year’s awardees will adapt a behavioral therapy for Deaf individuals, test a new treatment regimen for breast cancer patients with brain metastases, map brain pathways to aid surgery, and use artificial intelligence to support clinical decision making. 

National Study: Early Treatment with COVID Convalescent Plasma Prevents Hospitalization

National Study: Early Treatment with COVID Convalescent Plasma Prevents Hospitalization

The UR CTSI was part of a national study published in the New England Journal of Medicine showing that plasma from patients who have recovered from COVID is a safe and effective early outpatient treatment for others with the disease.